Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Mersana Therapeutics Current Ratio 2016-2020 | MRSN

Mersana Therapeutics current ratio from 2016 to 2020. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
  
Mersana Therapeutics Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2020-03-31 $0.08B $0.02B 4.59
2019-12-31 $0.10B $0.02B 4.21
2019-09-30 $0.12B $0.02B 5.12
2019-06-30 $0.13B $0.02B 5.50
2019-03-31 $0.14B $0.02B 6.24
2018-12-31 $0.07B $0.07B 1.07
2018-09-30 $0.09B $0.03B 2.86
2018-06-30 $0.10B $0.03B 3.21
2018-03-31 $0.11B $0.03B 3.80
2017-12-31 $0.12B $0.03B 3.69
2017-09-30 $0.14B $0.03B 5.58
2017-06-30 $0.08B $0.03B 2.53
2017-03-31 $0.00B 0.00
2016-12-31 $0.00B 0.00
2016-09-30 $0.00B 0.00
2016-06-30 $0.00B 0.00
2015-12-31 $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.282B $0.042B
Mersana Therapeutics, Inc. is a biotechnology company. It focused on discovering and developing a pipeline of antibody drug conjugates. The company's product candidates include XMT-1522 and XMT-1536 which are in clinical stage. Mersana Therapeutics, Inc. is based in CAMBRIDGE, United States.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $131.603B 14.49
Gilead Sciences (GILD) United States $91.895B 11.91
CSL (CSLLY) Australia $89.448B 0.00
Vertex Pharmaceuticals (VRTX) United States $73.705B 50.67
Regeneron Pharmaceuticals (REGN) United States $67.954B 26.19
Illumina (ILMN) United States $53.809B 55.29
Biogen (BIIB) United States $49.423B 8.46
Seattle Genetics (SGEN) United States $27.838B 0.00
Alexion Pharmaceuticals (ALXN) United States $25.678B 11.03
Moderna (MRNA) United States $22.225B 0.00
Incyte (INCY) United States $21.933B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $20.519B 0.00
BioMarin Pharmaceutical (BMRN) United States $19.590B 177.59
Genmab (GMAB) Denmark $19.447B 16.02
Genmab (GNMSF) Denmark $18.331B 54.42
Alnylam Pharmaceuticals (ALNY) United States $15.939B 0.00
Bio-Rad Laboratories (BIO.B) United States $13.825B 62.93
BeiGene (BGNE) Cayman Islands $13.019B 0.00
Exact Sciences (EXAS) United States $12.913B 0.00
Galapagos (GLPG) Belgium $12.822B 37.97
BioNTech SE (BNTX) Germany $11.852B 0.00
Sarepta Therapeutics (SRPT) United States $11.776B 0.00
Bio-Techne Corp (TECH) United States $10.085B 66.63
QIAGEN (QGEN) Netherlands $10.007B 29.10
ARGENX SE-ADR (ARGX) Netherlands $9.958B 0.00
Horizon Therapeutics Public (HZNP) Ireland $9.606B 23.64
Guardant Health (GH) United States $8.264B 0.00
Immunomedics (IMMU) United States $7.717B 0.00
ACADIA Pharmaceuticals (ACAD) United States $7.484B 0.00
Exelixis (EXEL) United States $7.443B 26.10
Ascendis Pharma (ASND) Denmark $7.006B 0.00
Repligen (RGEN) United States $6.976B 122.36
Acceleron Pharma (XLRN) United States $5.215B 0.00
Adaptive Biotechnologies (ADPT) United States $4.926B 0.00
MyoKardia (MYOK) United States $4.854B 0.00
Emergent Biosolutions (EBS) United States $4.682B 30.69
Reata Pharmaceuticals (RETA) United States $4.664B 0.00
Ultragenyx Pharmaceutical (RARE) United States $4.479B 0.00
Zai Lab (ZLAB) China $4.416B 0.00
Mirati Therapeutics (MRTX) United States $4.386B 0.00
Vir Biotechnology (VIR) United States $4.366B 0.00
China Biologic Products (CBPO) China $4.330B 24.07
MorphoSys AG (MOR) Germany $4.284B 33.22
Global Blood Therapeutics (GBT) United States $4.193B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $4.171B 91.15
Blueprint Medicines (BPMC) United States $3.832B 0.00
Bluebird Bio (BLUE) United States $3.625B 0.00
Momenta Pharmaceuticals (MNTA) United States $3.609B 0.00
Arena Pharmaceuticals (ARNA) United States $3.434B 0.00
Amicus Therapeutics (FOLD) United States $3.386B 0.00
Deciphera Pharmaceuticals (DCPH) United States $3.314B 0.00
Halozyme Therapeutics (HALO) United States $3.296B 0.00
Denali Therapeutics (DNLI) United States $3.001B 0.00
UniQure (QURE) Netherlands $2.919B 0.00
Novavax (NVAX) United States $2.877B 0.00
NeoGenomics (NEO) United States $2.766B 202.00
Insmed (INSM) United States $2.689B 0.00
Viela Bio (VIE) United States $2.660B 0.00
Alkermes (ALKS) Ireland $2.653B 52.22
Amarin (AMRN) Ireland $2.633B 0.00
Alector (ALEC) United States $2.600B 0.00
Fate Therapeutics (FATE) United States $2.484B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.483B 0.00
Inovio Pharmaceuticals (INO) United States $2.267B 0.00
Principia Biopharma (PRNB) United States $2.109B 0.00
Eidos Therapeutics (EIDX) United States $1.900B 0.00
Ligand Pharmaceuticals (LGND) United States $1.778B 69.23
Zymeworks (ZYME) Canada $1.770B 0.00
Epizyme (EPZM) United States $1.765B 0.00
Adverum Biotechnologies (ADVM) United States $1.696B 0.00
Sangamo Therapeutics (SGMO) United States $1.662B 0.00
Twist Bioscience (TWST) United States $1.595B 0.00
Arcus Biosciences (RCUS) United States $1.590B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.574B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.571B 0.00
Editas Medicine (EDIT) United States $1.552B 0.00
Akcea Therapeutics (AKCA) United States $1.525B 0.00
Mesoblast (MESO) Australia $1.524B 0.00
PHARMA MAR SA (PHMMF) Spain $1.514B 0.00
Beam Therapeutics (BEAM) United States $1.444B 0.00
Intra-Cellular Therapies (ITCI) United States $1.425B 0.00
Zealand Pharma (ZLDPF) Denmark $1.412B 0.00
Zealand Pharma (ZEAL) Denmark $1.410B 0.00
REGENXBIO (RGNX) United States $1.398B 0.00
NGM Biopharmaceuticals (NGM) United States $1.388B 0.00
Coherus BioSciences (CHRS) United States $1.359B 9.49
Arvinas (ARVN) United States $1.277B 0.00
I-Mab (IMAB) China $1.260B 0.00
Cytokineticsorporated (CYTK) United States $1.255B 0.00
Revance Therapeutics (RVNC) United States $1.217B 0.00
Compugen (CGEN) Israel $1.149B 0.00
Myriad Genetics (MYGN) United States $1.147B 59.19
Intellia Therapeutics (NTLA) United States $1.041B 0.00
Sorrento Therapeutics (SRNE) United States $1.000B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.969B 0.00
Athenex (ATNX) United States $0.969B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.937B 0.00
Pharming Group (PHGUF) Netherlands $0.895B 0.00
Cue Biopharma (CUE) United States $0.874B 0.00
Heska (HSKA) United States $0.814B 0.00
Cellectis S.A (CLLS) France $0.809B 0.00
Alcobra (ARCT) United States $0.799B 0.00
NextCure (NXTC) United States $0.789B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.773B 0.00
Codexis (CDXS) United States $0.754B 0.00
Kala Pharmaceuticals (KALA) United States $0.753B 0.00
Cara Therapeutics (CARA) United States $0.742B 0.00
Kadmon Holdings (KDMN) United States $0.741B 0.00
NantKwest (NK) United States $0.738B 0.00
Retrophin (RTRX) United States $0.726B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.713B 0.00
Agenus (AGEN) United States $0.681B 0.00
Intrexon (PGEN) United States $0.676B 0.00
Vericel (VCEL) United States $0.672B 124.08
ZIOPHARM Oncology Inc (ZIOP) United States $0.669B 0.00
Castle Biosciences (CSTL) United States $0.662B 0.00
Dynavax Technologies (DVAX) United States $0.662B 0.00
Bellus Health (BLU) Canada $0.642B 0.00
Sinovac Biotech (SVA) China $0.640B 17.03
Morphic Holding (MORF) United States $0.635B 0.00
Stemline Therapeutics (STML) United States $0.627B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.622B 5.33
Athersys (ATHX) United States $0.613B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.605B 0.00
Frequency Therapeutics (FREQ) United States $0.578B 0.00
AnaptysBio (ANAB) United States $0.555B 0.00
DBV Technologies S.A (DBVT) France $0.544B 0.00
Cel-Sci (CVM) United States $0.543B 0.00
Clovis Oncology (CLVS) United States $0.537B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.533B 0.00
MeiraGTx Holdings (MGTX) United States $0.517B 0.00
Scholar Rock Holding (SRRK) United States $0.514B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.513B 0.00
UROGEN PHARMA (URGN) United States $0.513B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.510B 0.00
VBI Vaccines (VBIV) United States $0.496B 0.00
Anika Therapeutics (ANIK) United States $0.495B 15.91
BioDelivery Sciences (BDSI) United States $0.477B 25.10
AC Immune SA (ACIU) Switzerland $0.474B 0.00
Protagonist Therapeutics (PTGX) United States $0.460B 0.00
Prothena (PRTA) Ireland $0.460B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.452B 0.00
Syros Pharmaceuticals (SYRS) United States $0.443B 0.00
Puma Biotechnology (PBYI) United States $0.443B 0.00
Merus (MRUS) Netherlands $0.422B 0.00
Albireo Pharma (ALBO) United States $0.411B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.403B 0.00
Precision BioSciences (DTIL) United States $0.400B 0.00
MiMedx (MDXG) United States $0.398B 0.00
Seres Therapeutics (MCRB) United States $0.393B 0.00
PDL BioPharma (PDLI) United States $0.378B 324.00
CytomX Therapeutics (CTMX) United States $0.373B 0.00
ANI Pharmaceuticals (ANIP) United States $0.367B 7.26
Avid Bioservices (CDMO) United States $0.356B 0.00
Kamada (KMDA) Israel $0.337B 14.00
Selecta Biosciences (SELB) United States $0.334B 0.00
WAVE Life Sciences (WVE) Singapore $0.334B 0.00
Geron (GERN) United States $0.333B 0.00
OSMOTICA PHARM (OSMT) United States $0.325B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.315B 0.00
Verastem (VSTM) United States $0.307B 0.00
MannKind (MNKD) United States $0.307B 0.00
Menlo Therapeutics (MNLO) United States $0.304B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.292B 0.00
ChromaDex (CDXC) United States $0.291B 0.00
Liquidia Technologies (LQDA) United States $0.287B 0.00
Spero Therapeutics (SPRO) United States $0.268B 0.00
Starpharma Holdings (SPHRY) Australia $0.266B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.264B 0.00
Affimed (AFMD) Germany $0.263B 0.00
Fortress Biotech (FBIO) United States $0.261B 0.00
Cellular Biomedicine (CBMG) United States $0.256B 0.00
Abeona Therapeutics (ABEO) United States $0.256B 0.00
Pfenex (PFNX) United States $0.255B 0.00
HOOKIPA Pharma (HOOK) United States $0.253B 0.00
ADMA Biologics Inc (ADMA) United States $0.250B 0.00
XOMA (XOMA) United States $0.249B 0.00
Prometic Life Sciences (LMNL) Canada $0.246B 0.00
Exicure (XCUR) United States $0.238B 0.00
Sutro Biopharma (STRO) United States $0.235B 0.00
Gritstone Oncology (GRTS) United States $0.234B 0.00
Northwest Biotherapeutics (NWBO) United States $0.224B 0.00
POXEL SA FRANCE (PXXLF) France $0.219B 0.00
IVERIC Bio (ISEE) United States $0.211B 0.00
Aduro Biotech (ADRO) United States $0.208B 0.00
ARAVIVE, INC (ARAV) United States $0.207B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.204B 3.08
GENFIT S.A (GNFT) France $0.199B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.198B 0.00
VTv Therapeutics (VTVT) United States $0.196B 0.00
IBio (IBIO) United States $0.194B 0.00
Five Prime Therapeutics (FPRX) United States $0.193B 0.00
Pluristem Therapeutics (PSTI) Israel $0.191B 0.00
Kindred Biosciences (KIN) United States $0.189B 0.00
Aytu Bioscience (AYTU) United States $0.186B 0.00
Strongbridge Biopharma (SBBP) United States $0.185B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.181B 0.00
TELA Bio (TELA) United States $0.177B 0.00
Cerecor (CERC) United States $0.174B 0.00
Dyadic (DYAI) United States $0.169B 0.00
Orgenesis (ORGS) United States $0.169B 0.00
Aptinyx (APTX) United States $0.163B 0.00
Celyad SA (CYAD) Belgium $0.163B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.159B 0.00
PHASEBIO PHARMA (PHAS) United States $0.153B 0.00
Cidara Therapeutics (CDTX) United States $0.151B 0.00
Trevena (TRVN) United States $0.147B 0.00
Biofrontera AG (BFRA) Germany $0.146B 0.00
Arbutus Biopharma (ABUS) Canada $0.144B 0.00
Enzo Biochem (ENZ) United States $0.144B 0.00
Theratechnologies (THTX) Canada $0.140B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.136B 0.00
Antibe Therapeutics (ATBPF) Canada $0.132B 0.00
VolitionRX (VNRX) United States $0.131B 0.00
Applied Genetic Technologies (AGTC) United States $0.128B 0.00
Palatin Technologies (PTN) United States $0.128B 3.28
AVEO Pharmaceuticals (AVEO) United States $0.127B 0.00
CorMedix Inc (CRMD) United States $0.122B 0.00
AIT Therapeutics (XAIR) United States $0.118B 0.00
Oncobiologics (OTLK) United States $0.118B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.115B 0.00
Cyclerion Therapeutics (CYCN) United States $0.114B 0.00
Checkpoint Therapeutics (CKPT) United States $0.113B 0.00
Lumos Pharma (LUMO) United States $0.113B 0.00
Protalix BioTherapeutics (PLX) Israel $0.111B 0.00
Eton Pharmaceuticals (ETON) United States $0.108B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.105B 0.00
Windtree Therapeutics (WINT) United States $0.099B 0.00
Catalyst Biosciences (CBIO) United States $0.093B 0.00
Organovo Holdings (ONVO) United States $0.091B 0.00
AquaBounty Technologies (AQB) United States $0.087B 0.00
AnPac Bio-Medical Science (ANPC) China $0.085B 0.00
SESEN BIO, INC (SESN) United States $0.085B 0.00
Clearside Biomedical (CLSD) United States $0.085B 0.00
Celsion (CLSN) United States $0.081B 0.00
Synlogic (SYBX) United States $0.081B 0.00
Emmaus Life Sciences (EMMA) United States $0.080B 0.00
Adocia (ADOCY) France $0.080B 0.00
Proteostasis Therapeutics (PTI) United States $0.074B 0.00
Idera Pharmaceuticals (IDRA) United States $0.071B 0.00
Stealth BioTherapeutics (MITO) United States $0.070B 0.00
Happiness Biotech Group (HAPP) China $0.069B 0.00
DiaMedica Therapeutics (DMAC) United States $0.066B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.065B 0.00
Vaccinex (VCNX) United States $0.063B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.061B 0.00
Ecology Coatings (ABVC) United States $0.058B 0.00
CollPlant Holdings (CLGN) Israel $0.058B 0.00
Signal Genetics (MGEN) United States $0.055B 0.00
Vascular Biogenics (VBLT) Israel $0.054B 0.00
Celldex Therapeutics (CLDX) United States $0.052B 0.00
Soligenix (SNGX) United States $0.051B 0.00
Apricus Biosciences (SEEL) United States $0.050B 0.00
Cocrystal Pharma (COCP) United States $0.049B 0.00
Advaxis (ADXS) United States $0.046B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.046B 0.00
Prima BioMed (IMMP) Australia $0.046B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.045B 0.00
OvaScience (MLND) United States $0.044B 0.00
Pulmatrix (PULM) United States $0.043B 0.00
Cesca Therapeutics (THMO) United States $0.042B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.041B 0.00
AmpliPhi Biosciences (ARMP) United States $0.041B 0.00
TrovaGene (CRDF) United States $0.041B 0.00
Chanticleer Holdings (SONN) United States $0.037B 0.00
Acorda Therapeutics (ACOR) United States $0.037B 0.00
ATyr Pharma (LIFE) United States $0.036B 0.00
TOCAGEN INC (TOCA) United States $0.030B 0.00
Curis (CRIS) United States $0.030B 0.00
Stellar Biotechnologies (EDSA) Canada $0.030B 0.00
BioCardia (BCDA) United States $0.028B 0.00
Evogene (EVGN) Israel $0.027B 0.00
AEterna Zentaris (AEZS) United States $0.027B 0.00
Titan Pharmaceuticals (TTNP) United States $0.026B 0.00
Alimera Sciences (ALIM) United States $0.026B 0.00
Bionano Genomics (BNGO) United States $0.025B 0.00
Spherix (AIKI) United States $0.024B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.024B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.022B 0.00
Entera Bio (ENTX) Israel $0.022B 0.00
Novogen (KZIA) Australia $0.021B 0.00
Cleveland BioLabs (CBLI) United States $0.020B 0.00
VIVUS (VVUS) United States $0.020B 0.00
Aptevo Therapeutics (APVO) United States $0.020B 0.00
Genetic Technologies (GENE) Australia $0.017B 0.00
Unum Therapeutics (UMRX) United States $0.017B 0.00
TRACON Pharmaceuticals (TCON) United States $0.012B 0.00
MYOS RENS Technology (MYOS) United States $0.010B 0.00
Prana Biotechnology (ATHE) Australia $0.008B 0.00
Neuralstem (SNCA) United States $0.008B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
IMMURON (IMRN) Australia $0.007B 0.00
BioPharmX (TMBR) United States $0.004B 0.00
Innate Pharma S.A (IPHA) France $0.000B 0.00